XTX Topco Ltd Has $101,000 Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

XTX Topco Ltd decreased its position in Teladoc Health, Inc. (NYSE:TDOC) by 47.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,030 shares of the health services provider’s stock after selling 10,016 shares during the period. XTX Topco Ltd’s holdings in Teladoc Health were worth $101,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after purchasing an additional 228,004 shares in the last quarter. Clearline Capital LP increased its holdings in Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock valued at $42,682,000 after buying an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company raised its stake in shares of Teladoc Health by 195.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider’s stock valued at $932,000 after buying an additional 63,028 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Teladoc Health during the 3rd quarter worth about $1,544,000. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Teladoc Health by 477.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock valued at $3,397,000 after acquiring an additional 305,961 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

TDOC opened at $9.44 on Friday. The stock has a market cap of $1.63 billion, a P/E ratio of -1.64 and a beta of 0.97. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $22.54. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $9.86 and a 200 day simple moving average of $9.13.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Jefferies Financial Group raised their target price on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Evercore ISI upped their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Finally, Barclays boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $12.24.

Insider Buying and Selling

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.95% of the stock is owned by company insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.